Global Anticancer Drugs Market Growth 2020-2025
According to this study, over the next five years the Anticancer Drugs market will register a 3.8%% CAGR in terms of revenue, the global market size will reach $ 95790 million by 2025, from $ 82440 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Anticancer Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Anticancer Drugs market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Anticancer Drugs, covering the supply chain analysis, impact assessment to the Anticancer Drugs market size growth rate in several scenarios, and the measures to be undertaken by Anticancer Drugs companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
Hormonal Drugs
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Lung Cancer
Breast Cancer
Leukemia
Colorectal Cancer
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
F. Hoffmann-La Roche Ltd
Merck & Co.
Eli Lilly and Company
Novartis AG
Pfizer Inc
CELGENE CORPORATION
AstraZeneca
Amgen Inc
Takeda Pharmaceutical Company Limited
Bayer AG
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Anticancer Drugs consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Anticancer Drugs market by identifying its various subsegments.
Focuses on the key global Anticancer Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anticancer Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Anticancer Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anticancer Drugs Consumption 2015-2025
2.1.2 Anticancer Drugs Consumption CAGR by Region
2.2 Anticancer Drugs Segment by Type
2.2.1 Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
2.2.2 Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
2.2.3 Hormonal Drugs
2.3 Anticancer Drugs Consumption by Type
2.3.1 Global Anticancer Drugs Consumption Market Share by Type (2015-2020)
2.3.2 Global Anticancer Drugs Revenue and Market Share by Type (2015-2020)
2.3.3 Global Anticancer Drugs Sale Price by Type (2015-2020)
2.4 Anticancer Drugs Segment by Application
2.4.1 Lung Cancer
2.4.2 Breast Cancer
2.4.3 Leukemia
2.4.4 Colorectal Cancer
2.4.5 Other
2.5 Anticancer Drugs Consumption by Application
2.5.1 Global Anticancer Drugs Consumption Market Share by Type (2015-2020)
2.5.2 Global Anticancer Drugs Value and Market Share by Type (2015-2020)
2.5.3 Global Anticancer Drugs Sale Price by Type (2015-2020)
3 Global Anticancer Drugs by Company
3.1 Global Anticancer Drugs Sales Market Share by Company
3.1.1 Global Anticancer Drugs Sales by Company (2018-2020)
3.1.2 Global Anticancer Drugs Sales Market Share by Company (2018-2020)
3.2 Global Anticancer Drugs Revenue Market Share by Company
3.2.1 Global Anticancer Drugs Revenue by Company (2018-2020)
3.2.2 Global Anticancer Drugs Revenue Market Share by Company (2018-2020)
3.3 Global Anticancer Drugs Sale Price by Company
3.4 Global Anticancer Drugs Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Anticancer Drugs Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Anticancer Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Anticancer Drugs by Regions
4.1 Anticancer Drugs by Regions
4.2 Americas Anticancer Drugs Consumption Growth
4.3 APAC Anticancer Drugs Consumption Growth
4.4 Europe Anticancer Drugs Consumption Growth
4.5 Middle East & Africa Anticancer Drugs Consumption Growth
5 Americas
5.1 Americas Anticancer Drugs Consumption by Countries
5.1.1 Americas Anticancer Drugs Consumption by Countries (2015-2020)
5.1.2 Americas Anticancer Drugs Value by Countries (2015-2020)
5.2 Americas Anticancer Drugs Consumption by Type
5.3 Americas Anticancer Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Anticancer Drugs Consumption by Regions
6.1.1 APAC Anticancer Drugs Consumption by Regions (2015-2020)
6.1.2 APAC Anticancer Drugs Value by Regions (2015-2020)
6.2 APAC Anticancer Drugs Consumption by Type
6.3 APAC Anticancer Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Anticancer Drugs by Countries
7.1.1 Europe Anticancer Drugs Consumption by Countries (2015-2020)
7.1.2 Europe Anticancer Drugs Value by Countries (2015-2020)
7.2 Europe Anticancer Drugs Consumption by Type
7.3 Europe Anticancer Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Anticancer Drugs by Countries
8.1.1 Middle East & Africa Anticancer Drugs Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Anticancer Drugs Value by Countries (2015-2020)
8.2 Middle East & Africa Anticancer Drugs Consumption by Type
8.3 Middle East & Africa Anticancer Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Anticancer Drugs Distributors
10.3 Anticancer Drugs Customer
11 Global Anticancer Drugs Market Forecast
11.1 Global Anticancer Drugs Consumption Forecast (2021-2025)
11.2 Global Anticancer Drugs Forecast by Regions
11.2.1 Global Anticancer Drugs Forecast by Regions (2021-2025)
11.2.2 Global Anticancer Drugs Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Anticancer Drugs Forecast by Type
11.8 Global Anticancer Drugs Forecast by Application
12 Key Players Analysis
12.1 F. Hoffmann-La Roche Ltd
12.1.1 Company Information
12.1.2 Anticancer Drugs Product Offered
12.1.3 F. Hoffmann-La Roche Ltd Anticancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 F. Hoffmann-La Roche Ltd Latest Developments
12.2 Merck & Co.
12.2.1 Company Information
12.2.2 Anticancer Drugs Product Offered
12.2.3 Merck & Co. Anticancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Merck & Co. Latest Developments
12.3 Eli Lilly and Company
12.3.1 Company Information
12.3.2 Anticancer Drugs Product Offered
12.3.3 Eli Lilly and Company Anticancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Eli Lilly and Company Latest Developments
12.4 Novartis AG
12.4.1 Company Information
12.4.2 Anticancer Drugs Product Offered
12.4.3 Novartis AG Anticancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Novartis AG Latest Developments
12.5 Pfizer Inc
12.5.1 Company Information
12.5.2 Anticancer Drugs Product Offered
12.5.3 Pfizer Inc Anticancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Pfizer Inc Latest Developments
12.6 CELGENE CORPORATION
12.6.1 Company Information
12.6.2 Anticancer Drugs Product Offered
12.6.3 CELGENE CORPORATION Anticancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 CELGENE CORPORATION Latest Developments
12.7 AstraZeneca
12.7.1 Company Information
12.7.2 Anticancer Drugs Product Offered
12.7.3 AstraZeneca Anticancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 AstraZeneca Latest Developments
12.8 Amgen Inc
12.8.1 Company Information
12.8.2 Anticancer Drugs Product Offered
12.8.3 Amgen Inc Anticancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Amgen Inc Latest Developments
12.9 Takeda Pharmaceutical Company Limited
12.9.1 Company Information
12.9.2 Anticancer Drugs Product Offered
12.9.3 Takeda Pharmaceutical Company Limited Anticancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Takeda Pharmaceutical Company Limited Latest Developments
12.10 Bayer AG
12.10.1 Company Information
12.10.2 Anticancer Drugs Product Offered
12.10.3 Bayer AG Anticancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Bayer AG Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Anticancer Drugs Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
Table 5. Major Players of Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
Table 6. Major Players of Hormonal Drugs
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Anticancer Drugs Consumption Market Share by Type (2015-2020)
Table 9. Global Anticancer Drugs Revenue by Type (2015-2020) ($ million)
Table 10. Global Anticancer Drugs Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Anticancer Drugs Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Anticancer Drugs Consumption Market Share by Application (2015-2020)
Table 14. Global Anticancer Drugs Value by Application (2015-2020)
Table 15. Global Anticancer Drugs Value Market Share by Application (2015-2020)
Table 16. Global Anticancer Drugs Sale Price by Application (2015-2020)
Table 17. Global Anticancer Drugs Sales by Company (2017-2019) (MT)
Table 18. Global Anticancer Drugs Sales Market Share by Company (2017-2019)
Table 19. Global Anticancer Drugs Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Anticancer Drugs Revenue Market Share by Company (2017-2019)
Table 21. Global Anticancer Drugs Sale Price by Company (2017-2019)
Table 22. Global Anticancer Drugs Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Anticancer Drugs Products Offered
Table 24. Anticancer Drugs Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Anticancer Drugs Consumption by Regions 2015-2020 (MT)
Table 26. Global Anticancer Drugs Consumption Market Share by Regions 2015-2020
Table 27. Global Anticancer Drugs Value by Regions 2015-2020 ($ Millions)
Table 28. Global Anticancer Drugs Value Market Share by Regions 2015-2020
Table 29. Americas Anticancer Drugs Consumption by Countries (2015-2020) (MT)
Table 30. Americas Anticancer Drugs Consumption Market Share by Countries (2015-2020)
Table 31. Americas Anticancer Drugs Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Anticancer Drugs Value Market Share by Countries (2015-2020)
Table 33. Americas Anticancer Drugs Consumption by Type (2015-2020) (MT)
Table 34. Americas Anticancer Drugs Consumption Market Share by Type (2015-2020)
Table 35. Americas Anticancer Drugs Consumption by Application (2015-2020) (MT)
Table 36. Americas Anticancer Drugs Consumption Market Share by Application (2015-2020)
Table 37. APAC Anticancer Drugs Consumption by Regions (2015-2020) (MT)
Table 38. APAC Anticancer Drugs Consumption Market Share by Regions (2015-2020)
Table 39. APAC Anticancer Drugs Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Anticancer Drugs Value Market Share by Regions (2015-2020)
Table 41. APAC Anticancer Drugs Consumption by Type (2015-2020) (MT)
Table 42. APAC Anticancer Drugs Consumption Market Share by Type (2015-2020)
Table 43. APAC Anticancer Drugs Consumption by Application (2015-2020) (MT)
Table 44. APAC Anticancer Drugs Consumption Market Share by Application (2015-2020)
Table 45. Europe Anticancer Drugs Consumption by Countries (2015-2020) (MT)
Table 46. Europe Anticancer Drugs Consumption Market Share by Countries (2015-2020)
Table 47. Europe Anticancer Drugs Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Anticancer Drugs Value Market Share by Countries (2015-2020)
Table 49. Europe Anticancer Drugs Consumption by Type (2015-2020) (MT)
Table 50. Europe Anticancer Drugs Consumption Market Share by Type (2015-2020)
Table 51. Europe Anticancer Drugs Consumption by Application (2015-2020) (MT)
Table 52. Europe Anticancer Drugs Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Anticancer Drugs Consumption by Countries (2015-2020) (MT)
Table 54. Middle East & Africa Anticancer Drugs Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Anticancer Drugs Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Anticancer Drugs Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Anticancer Drugs Consumption by Type (2015-2020) (MT)
Table 58. Middle East & Africa Anticancer Drugs Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Anticancer Drugs Consumption by Application (2015-2020) (MT)
Table 60. Middle East & Africa Anticancer Drugs Consumption Market Share by Application (2015-2020)
Table 61. Anticancer Drugs Distributors List
Table 62. Anticancer Drugs Customer List
Table 63. Global Anticancer Drugs Consumption Forecast by Countries (2021-2025) (MT)
Table 64. Global Anticancer Drugs Consumption Market Forecast by Regions
Table 65. Global Anticancer Drugs Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Anticancer Drugs Value Market Share Forecast by Regions
Table 67. Global Anticancer Drugs Consumption Forecast by Type (2021-2025) (MT)
Table 68. Global Anticancer Drugs Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Anticancer Drugs Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Anticancer Drugs Value Market Share Forecast by Type (2021-2025)
Table 71. Global Anticancer Drugs Consumption Forecast by Application (2021-2025) (MT)
Table 72. Global Anticancer Drugs Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Anticancer Drugs Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Anticancer Drugs Value Market Share Forecast by Application (2021-2025)
Table 75. F. Hoffmann-La Roche Ltd Product Offered
Table 76. F. Hoffmann-La Roche Ltd Anticancer Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 77. F. Hoffmann-La Roche Ltd Main Business
Table 78. F. Hoffmann-La Roche Ltd Latest Developments
Table 79. F. Hoffmann-La Roche Ltd Basic Information, Company Total Revenue (in $ million), Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck & Co. Product Offered
Table 81. Merck & Co. Anticancer Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 82. Merck & Co. Main Business
Table 83. Merck & Co. Latest Developments
Table 84. Merck & Co. Basic Information, Company Total Revenue (in $ million), Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Eli Lilly and Company Product Offered
Table 86. Eli Lilly and Company Anticancer Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 87. Eli Lilly and Company Main Business
Table 88. Eli Lilly and Company Latest Developments
Table 89. Eli Lilly and Company Basic Information, Company Total Revenue (in $ million), Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Novartis AG Product Offered
Table 91. Novartis AG Anticancer Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 92. Novartis AG Main Business
Table 93. Novartis AG Latest Developments
Table 94. Novartis AG Basic Information, Company Total Revenue (in $ million), Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer Inc Product Offered
Table 96. Pfizer Inc Anticancer Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 97. Pfizer Inc Main Business
Table 98. Pfizer Inc Latest Developments
Table 99. Pfizer Inc Basic Information, Company Total Revenue (in $ million), Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. CELGENE CORPORATION Product Offered
Table 101. CELGENE CORPORATION Anticancer Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 102. CELGENE CORPORATION Main Business
Table 103. CELGENE CORPORATION Latest Developments
Table 104. CELGENE CORPORATION Basic Information, Company Total Revenue (in $ million), Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. AstraZeneca Product Offered
Table 106. AstraZeneca Basic Information, Company Total Revenue (in $ million), Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. AstraZeneca Main Business
Table 108. AstraZeneca Latest Developments
Table 109. AstraZeneca Anticancer Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 110. Amgen Inc Product Offered
Table 111. Amgen Inc Anticancer Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 112. Amgen Inc Main Business
Table 113. Amgen Inc Latest Developments
Table 114. Amgen Inc Basic Information, Company Total Revenue (in $ million), Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Takeda Pharmaceutical Company Limited Product Offered
Table 116. Takeda Pharmaceutical Company Limited Anticancer Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 117. Takeda Pharmaceutical Company Limited Main Business
Table 118. Takeda Pharmaceutical Company Limited Latest Developments
Table 119. Takeda Pharmaceutical Company Limited Basic Information, Company Total Revenue (in $ million), Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Bayer AG Product Offered
Table 121. Bayer AG Anticancer Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 122. Bayer AG Main Business
Table 123. Bayer AG Latest Developments
Table 124. Bayer AG Basic Information, Company Total Revenue (in $ million), Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Anticancer Drugs
Figure 2. Anticancer Drugs Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Anticancer Drugs Consumption Growth Rate 2015-2025 (MT)
Figure 5. Global Anticancer Drugs Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
Figure 7. Product Picture of Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
Figure 8. Product Picture of Hormonal Drugs
Figure 9. Global Anticancer Drugs Consumption Market Share by Type (2015-2020)
Figure 10. Global Anticancer Drugs Value Market Share by Type (2015-2020)
Figure 11. Anticancer Drugs Consumed in Lung Cancer
Figure 12. Global Anticancer Drugs Market: Lung Cancer (2015-2020) (MT)
Figure 13. Global Anticancer Drugs Market: Lung Cancer (2015-2020) ($ Millions)
Figure 14. Anticancer Drugs Consumed in Breast Cancer
Figure 15. Global Anticancer Drugs Market: Breast Cancer (2015-2020) (MT)
Figure 16. Global Anticancer Drugs Market: Breast Cancer (2015-2020) ($ Millions)
Figure 17. Anticancer Drugs Consumed in Leukemia
Figure 18. Global Anticancer Drugs Market: Leukemia (2015-2020) (MT)
Figure 19. Global Anticancer Drugs Market: Leukemia (2015-2020) ($ Millions)
Figure 20. Anticancer Drugs Consumed in Colorectal Cancer
Figure 21. Global Anticancer Drugs Market: Colorectal Cancer (2015-2020) (MT)
Figure 22. Global Anticancer Drugs Market: Colorectal Cancer (2015-2020) ($ Millions)
Figure 23. Anticancer Drugs Consumed in Other
Figure 24. Global Anticancer Drugs Market: Other (2015-2020) (MT)
Figure 25. Global Anticancer Drugs Market: Other (2015-2020) ($ Millions)
Figure 26. Global Anticancer Drugs Consumption Market Share by Application (2015-2020)
Figure 27. Global Anticancer Drugs Value Market Share by Application (2015-2020)
Figure 28. Global Anticancer Drugs Sales Market Share by Company in 2017
Figure 29. Global Anticancer Drugs Sales Market Share by Company in 2019
Figure 30. Global Anticancer Drugs Revenue Market Share by Company in 2017
Figure 31. Global Anticancer Drugs Revenue Market Share by Company in 2019
Figure 32. Global Anticancer Drugs Sale Price by Company in 2019
Figure 33. Global Anticancer Drugs Consumption Market Share by Regions 2015-2020
Figure 34. Global Anticancer Drugs Value Market Share by Regions 2015-2020
Figure 35. Americas Anticancer Drugs Consumption 2015-2020 (MT)
Figure 36. Americas Anticancer Drugs Value 2015-2020 ($ Millions)
Figure 37. APAC Anticancer Drugs Consumption 2015-2020 (MT)
Figure 38. APAC Anticancer Drugs Value 2015-2020 ($ Millions)
Figure 39. Europe Anticancer Drugs Consumption 2015-2020 (MT)
Figure 40. Europe Anticancer Drugs Value 2015-2020 ($ Millions)
Figure 41. Middle East & Africa Anticancer Drugs Consumption 2015-2020 (MT)
Figure 42. Middle East & Africa Anticancer Drugs Value 2015-2020 ($ Millions)
Figure 43. Americas Anticancer Drugs Consumption Market Share by Countries in 2019
Figure 44. Americas Anticancer Drugs Value Market Share by Countries in 2019
Figure 45. Americas Anticancer Drugs Consumption Market Share by Type in 2019
Figure 46. Americas Anticancer Drugs Consumption Market Share by Application in 2019
Figure 47. United States Anticancer Drugs Consumption Growth 2015-2020 (MT)
Figure 48. United States Anticancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 49. Canada Anticancer Drugs Consumption Growth 2015-2020 (MT)
Figure 50. Canada Anticancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 51. Mexico Anticancer Drugs Consumption Growth 2015-2020 (MT)
Figure 52. Mexico Anticancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 53. APAC Anticancer Drugs Consumption Market Share by Countries in 2019
Figure 54. APAC Anticancer Drugs Value Market Share by Regions in 2019
Figure 55. APAC Anticancer Drugs Consumption Market Share by Type in 2019
Figure 56. APAC Anticancer Drugs Consumption Market Share by Application in 2019
Figure 57. China Anticancer Drugs Consumption Growth 2015-2020 (MT)
Figure 58. China Anticancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 59. Japan Anticancer Drugs Consumption Growth 2015-2020 (MT)
Figure 60. Japan Anticancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 61. Korea Anticancer Drugs Consumption Growth 2015-2020 (MT)
Figure 62. Korea Anticancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 63. Southeast Asia Anticancer Drugs Consumption Growth 2015-2020 (MT)
Figure 64. Southeast Asia Anticancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 65. India Anticancer Drugs Consumption Growth 2015-2020 (MT)
Figure 66. India Anticancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 67. Australia Anticancer Drugs Consumption Growth 2015-2020 (MT)
Figure 68. Australia Anticancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 69. Europe Anticancer Drugs Consumption Market Share by Countries in 2019
Figure 70. Europe Anticancer Drugs Value Market Share by Countries in 2019
Figure 71. Europe Anticancer Drugs Consumption Market Share by Type in 2019
Figure 72. Europe Anticancer Drugs Consumption Market Share by Application in 2019
Figure 73. Germany Anticancer Drugs Consumption Growth 2015-2020 (MT)
Figure 74. Germany Anticancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 75. France Anticancer Drugs Consumption Growth 2015-2020 (MT)
Figure 76. France Anticancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 77. UK Anticancer Drugs Consumption Growth 2015-2020 (MT)
Figure 78. UK Anticancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 79. Italy Anticancer Drugs Consumption Growth 2015-2020 (MT)
Figure 80. Italy Anticancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 81. Russia Anticancer Drugs Consumption Growth 2015-2020 (MT)
Figure 82. Russia Anticancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 83. Middle East & Africa Anticancer Drugs Consumption Market Share by Countries in 2019
Figure 84. Middle East & Africa Anticancer Drugs Value Market Share by Countries in 2019
Figure 85. Middle East & Africa Anticancer Drugs Consumption Market Share by Type in 2019
Figure 86. Middle East & Africa Anticancer Drugs Consumption Market Share by Application in 2019
Figure 87. Egypt Anticancer Drugs Consumption Growth 2015-2020 (MT)
Figure 88. Egypt Anticancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 89. South Africa Anticancer Drugs Consumption Growth 2015-2020 (MT)
Figure 90. South Africa Anticancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 91. Israel Anticancer Drugs Consumption Growth 2015-2020 (MT)
Figure 92. Israel Anticancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 93. Turkey Anticancer Drugs Consumption Growth 2015-2020 (MT)
Figure 94. Turkey Anticancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 95. GCC Countries Anticancer Drugs Consumption Growth 2015-2020 (MT)
Figure 96. GCC Countries Anticancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 97. Global Anticancer Drugs Consumption Growth Rate Forecast (2021-2025) (MT)
Figure 98. Global Anticancer Drugs Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 99. Americas Anticancer Drugs Consumption 2021-2025 (MT)
Figure 100. Americas Anticancer Drugs Value 2021-2025 ($ Millions)
Figure 101. APAC Anticancer Drugs Consumption 2021-2025 (MT)
Figure 102. APAC Anticancer Drugs Value 2021-2025 ($ Millions)
Figure 103. Europe Anticancer Drugs Consumption 2021-2025 (MT)
Figure 104. Europe Anticancer Drugs Value 2021-2025 ($ Millions)
Figure 105. Middle East & Africa Anticancer Drugs Consumption 2021-2025 (MT)
Figure 106. Middle East & Africa Anticancer Drugs Value 2021-2025 ($ Millions)
Figure 107. United States Anticancer Drugs Consumption 2021-2025 (MT)
Figure 108. United States Anticancer Drugs Value 2021-2025 ($ Millions)
Figure 109. Canada Anticancer Drugs Consumption 2021-2025 (MT)
Figure 110. Canada Anticancer Drugs Value 2021-2025 ($ Millions)
Figure 111. Mexico Anticancer Drugs Consumption 2021-2025 (MT)
Figure 112. Mexico Anticancer Drugs Value 2021-2025 ($ Millions)
Figure 113. Brazil Anticancer Drugs Consumption 2021-2025 (MT)
Figure 114. Brazil Anticancer Drugs Value 2021-2025 ($ Millions)
Figure 115. China Anticancer Drugs Consumption 2021-2025 (MT)
Figure 116. China Anticancer Drugs Value 2021-2025 ($ Millions)
Figure 117. Japan Anticancer Drugs Consumption 2021-2025 (MT)
Figure 118. Japan Anticancer Drugs Value 2021-2025 ($ Millions)
Figure 119. Korea Anticancer Drugs Consumption 2021-2025 (MT)
Figure 120. Korea Anticancer Drugs Value 2021-2025 ($ Millions)
Figure 121. Southeast Asia Anticancer Drugs Consumption 2021-2025 (MT)
Figure 122. Southeast Asia Anticancer Drugs Value 2021-2025 ($ Millions)
Figure 123. India Anticancer Drugs Consumption 2021-2025 (MT)
Figure 124. India Anticancer Drugs Value 2021-2025 ($ Millions)
Figure 125. Australia Anticancer Drugs Consumption 2021-2025 (MT)
Figure 126. Australia Anticancer Drugs Value 2021-2025 ($ Millions)
Figure 127. Germany Anticancer Drugs Consumption 2021-2025 (MT)
Figure 128. Germany Anticancer Drugs Value 2021-2025 ($ Millions)
Figure 129. France Anticancer Drugs Consumption 2021-2025 (MT)
Figure 130. France Anticancer Drugs Value 2021-2025 ($ Millions)
Figure 131. UK Anticancer Drugs Consumption 2021-2025 (MT)
Figure 132. UK Anticancer Drugs Value 2021-2025 ($ Millions)
Figure 133. Italy Anticancer Drugs Consumption 2021-2025 (MT)
Figure 134. Italy Anticancer Drugs Value 2021-2025 ($ Millions)
Figure 135. Russia Anticancer Drugs Consumption 2021-2025 (MT)
Figure 136. Russia Anticancer Drugs Value 2021-2025 ($ Millions)
Figure 137. Spain Anticancer Drugs Consumption 2021-2025 (MT)
Figure 138. Spain Anticancer Drugs Value 2021-2025 ($ Millions)
Figure 139. Egypt Anticancer Drugs Consumption 2021-2025 (MT)
Figure 140. Egypt Anticancer Drugs Value 2021-2025 ($ Millions)
Figure 141. South Africa Anticancer Drugs Consumption 2021-2025 (MT)
Figure 142. South Africa Anticancer Drugs Value 2021-2025 ($ Millions)
Figure 143. Israel Anticancer Drugs Consumption 2021-2025 (MT)
Figure 144. Israel Anticancer Drugs Value 2021-2025 ($ Millions)
Figure 145. Turkey Anticancer Drugs Consumption 2021-2025 (MT)
Figure 146. Turkey Anticancer Drugs Value 2021-2025 ($ Millions)
Figure 147. GCC Countries Anticancer Drugs Consumption 2021-2025 (MT)
Figure 148. GCC Countries Anticancer Drugs Value 2021-2025 ($ Millions)
Figure 149. F. Hoffmann-La Roche Ltd Anticancer Drugs Market Share (2018-2020)
Figure 150. Merck & Co. Anticancer Drugs Market Share (2018-2020)
Figure 151. Eli Lilly and Company Anticancer Drugs Market Share (2018-2020)
Figure 152. Novartis AG Anticancer Drugs Market Share (2018-2020)
Figure 153. Pfizer Inc Anticancer Drugs Market Share (2018-2020)
Figure 154. CELGENE CORPORATION Anticancer Drugs Market Share (2018-2020)
Figure 155. AstraZeneca Anticancer Drugs Market Share (2018-2020)
Figure 156. Amgen Inc Anticancer Drugs Market Share (2018-2020)
Figure 157. Takeda Pharmaceutical Company Limited Anticancer Drugs Market Share (2018-2020)
Figure 158. Bayer AG Anticancer Drugs Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets